Praxis Precision Medicines (PRAX) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to 0.87.
- Praxis Precision Medicines' Equity Ratio fell 573.44% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 573.44%. This contributed to the annual value of 0.92 for FY2024, which is 1639.63% up from last year.
- Praxis Precision Medicines' Equity Ratio amounted to 0.87 in Q3 2025, which was down 573.44% from 0.89 recorded in Q2 2025.
- Praxis Precision Medicines' Equity Ratio's 5-year high stood at 0.95 during Q2 2024, with a 5-year trough of 0.66 in Q1 2023.
- Over the past 4 years, Praxis Precision Medicines' median Equity Ratio value was 0.81 (recorded in 2023), while the average stood at 0.83.
- As far as peak fluctuations go, Praxis Precision Medicines' Equity Ratio crashed by 1784.13% in 2023, and later soared by 3997.64% in 2024.
- Quarter analysis of 4 years shows Praxis Precision Medicines' Equity Ratio stood at 0.66 in 2022, then grew by 19.83% to 0.79 in 2023, then rose by 16.4% to 0.92 in 2024, then fell by 6.01% to 0.87 in 2025.
- Its Equity Ratio stands at 0.87 for Q3 2025, versus 0.89 for Q2 2025 and 0.92 for Q1 2025.